These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 3274802)

  • 21. Prolonged heart allograft survival resulted from donor-specific T-cell sequestering and removal by selective splenectomy in mice.
    Zhu XH; Chen S; Chen ZK
    Transplant Proc; 2004 Oct; 36(8):2448-9. PubMed ID: 15561276
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Donor double-negative Treg promote allogeneic mixed chimerism and tolerance.
    He KM; Ma Y; Wang S; Min WP; Zhong R; Jevnikar A; Zhang ZX
    Eur J Immunol; 2007 Dec; 37(12):3455-66. PubMed ID: 18000953
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of the maintenance of transplantation tolerance.
    Moran T; Dittmer J; Bennett M
    Transplant Proc; 1981 Mar; 13(1 Pt 1):611-3. PubMed ID: 6455804
    [No Abstract]   [Full Text] [Related]  

  • 24. Persistence of donor-reactive T cells after liver transplantation-induced tolerance in mice.
    Dahmen U; Sun H; Demetris AJ; Fung J; Duquesnoy RJ; Qian S
    Transplant Proc; 1993 Feb; 25(1 Pt 1):334-5. PubMed ID: 8438324
    [No Abstract]   [Full Text] [Related]  

  • 25. [Study on the improved effect of anti-TCR alpha beta monoclonal antibody on the induction of transplantation tolerance to the allogeneic skin graft in mice and its mechanisms].
    Hao J; Liu J; Xie S
    Zhonghua Yi Xue Za Zhi; 2001 May; 81(10):593-6. PubMed ID: 11798930
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Donor-specific tolerance in a murine model: the result of extra-thymic T cell deletion?
    van Pel M; van Breugel DW; van Wijk M; Luypen S; Vingerhoed J; Roholl PJ; Boog CJ
    Transpl Immunol; 2003; 11(3-4):375-84. PubMed ID: 12967790
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Anti-NK cell treatment induces stable mixed chimerism in MHC-mismatched, T cell-depleted, nonmyeloablative bone marrow transplantation.
    Cho SG; Shuto Y; Soda Y; Nakazaki Y; Izawa K; Uchimaru K; Takahashi S; Tani K; Tojo A; Asano S
    Exp Hematol; 2004 Dec; 32(12):1246-54. PubMed ID: 15588949
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nature of tolerance induction to peripheral (extrathymic) islet allografts.
    Coulombe M; Lafferty KJ; Gill RG
    Transplant Proc; 1994 Apr; 26(2):720-1. PubMed ID: 8171624
    [No Abstract]   [Full Text] [Related]  

  • 29. Immunohematopoietic reconstitution by allogeneic and autologous bone marrow grafts as a means for induction of specific unresponsiveness to donor-specific allografts and modified self in autoimmune disorders.
    Slavin S; Karussis D; Weiss L; Vourka-Karussis U; Abramsky O
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1274-5. PubMed ID: 8442110
    [No Abstract]   [Full Text] [Related]  

  • 30. Apoptotic donor leukocytes limit mixed-chimerism induced by CD40-CD154 blockade in allogeneic bone marrow transplantation.
    Li JM; Gorechlad J; Larsen CP; Waller EK
    Biol Blood Marrow Transplant; 2006 Dec; 12(12):1239-49. PubMed ID: 17162205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
    He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
    Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic characterization of tumor-associated transplantation antigens on MM102 mammary tumor eliciting preferentially helper T cell activity.
    Fujiwara H; Aoki H; Tsuchida T; Hamaoka T
    J Immunol; 1978 Oct; 121(4):1591-5. PubMed ID: 308971
    [No Abstract]   [Full Text] [Related]  

  • 33. MHC fully allogeneic bone transplantation after physical T-cell depletion with magnetic microspheres (MAMIS).
    Leyhausen G; Winoto-Morbach S; Blank M; Müller-Ruchholtz W
    Transplant Proc; 1989 Feb; 21(1 Pt 3):2943-6. PubMed ID: 2650401
    [No Abstract]   [Full Text] [Related]  

  • 34. Adoptive transfer of specific unresponsiveness to skin allografts by spleen cells from ALS-treated, marrow-injected mice.
    Wood ML; Monaco AP
    Transplant Proc; 1979 Mar; 11(1):1023-7. PubMed ID: 377604
    [No Abstract]   [Full Text] [Related]  

  • 35. The collaboration of H-2 identical bone marrow cells in in vivo antitumor activity of immune mouse splenocytes.
    Ozawa H; Iwaguchi T; Kataoka T
    Jpn J Cancer Res; 1987 Feb; 78(2):113-6. PubMed ID: 3104253
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Suppression of donor lymphocyte reactivity by pretreatment with recipient type UV-irradiated blood.
    Polijak-Blazi M; Hadzija M
    Transplant Proc; 1987 Feb; 19(1 Pt 2):944-5. PubMed ID: 3274434
    [No Abstract]   [Full Text] [Related]  

  • 37. Transfer of B memory cells to a T-dependent antigen in murine bone marrow transplantation.
    Tsuberi B; Slavin S; Kedar E; Leshem B
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2747-9. PubMed ID: 3274586
    [No Abstract]   [Full Text] [Related]  

  • 38. Possible manipulations of allograft tolerance by suppressor cells.
    Hilgert I; Rieger M; Kristofová H; Vlachov K; Singh SK
    Transplant Proc; 1979 Mar; 11(1):887-90. PubMed ID: 88103
    [No Abstract]   [Full Text] [Related]  

  • 39. Tolerance induction in mice by conjugates of monoclonal immunoglobulins and monomethoxypolyethylene glycol. Transfer of tolerance by T cells and by T cell extracts.
    Wilkinson I; Jackson CJ; Lang GM; Holford-Strevens V; Sehon AH
    J Immunol; 1987 Jul; 139(2):326-31. PubMed ID: 2955036
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The activity of nonspecific bone marrow and spleen suppressors in the latent period of tumor growth].
    Ogreba VI; Kusmartsev SA; Vasil'ev NV
    Vopr Onkol; 1988; 34(8):952-5. PubMed ID: 2971291
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.